Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (221-230 of 522) with videos related to

Pageof 53
Sort By:
Biomedicines|May 16, 2023
Timing Is Important-Management of Metabolic Syndrome According to the Circadian RhythmKsenija Zečević, Nataša Popović, Aleksandra Vuksanović Božarić, et al.
Metabolism: Clinical and Experimental|January 21, 2026
Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyondEmir Muzurović, Niki Katsiki, Špela Volčanšek, et al.
Expert Opinion on Pharmacotherapy|August 20, 2008
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?Manfredi Rizzo, Emanuel R Christ, Giovam Battista Rini, et al.
Current Pharmaceutical Design|September 18, 2013
Statins and new-onset diabetesMarcin Barylski, Dragana Nikolic, Maciej Banach, et al.
International Journal of Molecular Sciences|July 2, 2021
The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the HeartTeoman Dogru, Ali Kirik, Hasan Gurel, et al.
International Journal of Molecular Sciences|November 27, 2021
Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic AgentsJelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionalityMarcin Barylski, Peter P Toth, Dragana Nikolic, et al.
Expert Opinion on Drug Safety|November 25, 2025
The Safety, Efficacy, and Clinical Use of Novel Once-Weekly Insulins in the Management of DiabetesAmanda DeLuca, Ashley Schultz, Hannah Ofori, et al.
Biomedicines|November 26, 2022
Role of Chemerin in Cardiovascular DiseasesMirjana T Macvanin, Manfredi Rizzo, Jelena Radovanovic, et al.
Stroke|December 24, 2005
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up studyEgle Corrado, Manfredi Rizzo, Rosalba Tantillo, et al.
Pageof 53

Showing results (221-230 of 522) with videos related to

Sort By:
Pageof 53
Biomedicines|May 16, 2023
Timing Is Important-Management of Metabolic Syndrome According to the Circadian RhythmKsenija Zečević, Nataša Popović, Aleksandra Vuksanović Božarić, et al.
Metabolism: Clinical and Experimental|January 21, 2026
Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyondEmir Muzurović, Niki Katsiki, Špela Volčanšek, et al.
Expert Opinion on Pharmacotherapy|August 20, 2008
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?Manfredi Rizzo, Emanuel R Christ, Giovam Battista Rini, et al.
Current Pharmaceutical Design|September 18, 2013
Statins and new-onset diabetesMarcin Barylski, Dragana Nikolic, Maciej Banach, et al.
International Journal of Molecular Sciences|July 2, 2021
The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the HeartTeoman Dogru, Ali Kirik, Hasan Gurel, et al.
International Journal of Molecular Sciences|November 27, 2021
Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic AgentsJelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionalityMarcin Barylski, Peter P Toth, Dragana Nikolic, et al.
Expert Opinion on Drug Safety|November 25, 2025
The Safety, Efficacy, and Clinical Use of Novel Once-Weekly Insulins in the Management of DiabetesAmanda DeLuca, Ashley Schultz, Hannah Ofori, et al.
Biomedicines|November 26, 2022
Role of Chemerin in Cardiovascular DiseasesMirjana T Macvanin, Manfredi Rizzo, Jelena Radovanovic, et al.
Stroke|December 24, 2005
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up studyEgle Corrado, Manfredi Rizzo, Rosalba Tantillo, et al.
Pageof 53